A clinical trial of the I-WOTCH program shows it helps patients safely taper off strong opioids without compromising their quality of life.
Key facts
- •The I-WOTCH program helped 29% of participants stop using strong opioids within one year, compared to 7% in the standard care group.
- •In 2019, 5.6 million people in England received prescriptions for opioid painkillers.
- •The study was conducted at general practitioners' offices across England with over 600 patients.
- •Long-term opioid use is linked to risks such as overdose, sleep apnea, and early death.
- •Researchers plan to conduct further studies to determine if the self-regulation habits formed by participants remain lifelong.
A new study indicates that the Improving the Well-being of People with Opioid Treated Chronic Pain (I-WOTCH) program helps patients successfully self-regulate their use of strong opioid painkillers. Conducted across general practitioners' offices in England, the yearlong trial found that participants receiving support were significantly more likely to stop using strong opioids than those receiving standard care.
By the numbers
Trial Results and Methodology
The clinical trial involved more than 600 patients suffering from nonmalignant chronic pain. After 12 months, 29% of participants in the I-WOTCH support group had stopped using strong opioids entirely, compared to 7% of patients who received standard care without the program's support. Researchers noted that the program enabled these reductions without causing a decline in the patients' health-related quality of life.
Economic Evaluation and NHS Impact
An economic analysis published in the journal Addiction suggests that while the I-WOTCH program requires higher upfront costs due to the need for additional medical support during the tapering process, it represents a potentially cost-effective investment for the NHS in the long term. By teaching patients to manage chronic pain through self-management techniques and reserving opioids only for acute, short-term pain, the program aims to reduce the risks of dependency and long-term health complications.
Risks of Long-Term Opioid Use
Experts highlight that while strong opioids are effective for sudden, short-term pain, there is limited evidence supporting their long-term use for chronic pain unrelated to cancer. Continued use is associated with severe risks, including sleep apnea, falls, dizziness, overdose, and premature death. Current NICE guidance recommends that patients taper or stop using these medications when the associated risks outweigh the benefits.
Advertisement
This article was independently rewritten by ManyPress editorial AI from reporting originally published by Medical Xpress.
